The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8470800, D::US8609833, 93 ID: ALA3642152
PubChem CID: 49784884
Max Phase: Preclinical
Molecular Formula: C14H18N6O7
Molecular Weight: 382.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=[N+]([O-])OC[C@H]1O[C@@H](n2cnc3c(NC4CCOC4)ncnc32)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C14H18N6O7/c21-10-8(4-26-20(23)24)27-14(11(10)22)19-6-17-9-12(15-5-16-13(9)19)18-7-1-2-25-3-7/h5-8,10-11,14,21-22H,1-4H2,(H,15,16,18)/t7?,8-,10-,11-,14-/m1/s1
Standard InChI Key: QKLWYFLDTCIMJQ-HVMNINKTSA-N
Molfile:
RDKit 2D
27 30 0 0 1 0 0 0 0 0999 V2000
-2.0533 -7.3748 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8348 -6.1949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8675 -5.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3525 -5.3058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9246 -6.6933 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.4122 -6.8924 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.8697 -8.0018 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.1445 -5.9418 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1519 -3.7886 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.6928 -4.0817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4810 -5.5489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5772 -6.1149 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5972 1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8056 3.8680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3371 5.2929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8371 5.2877 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3786 3.8595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 6
2 3 1 0
3 4 1 1
4 5 1 0
5 6 1 0
6 7 2 0
6 8 1 0
3 9 1 0
9 10 1 0
10 11 1 0
11 2 1 0
11 12 1 6
10 13 1 1
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 19 1 0
17 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 13 1 0
27 16 1 0
M CHG 2 6 1 8 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 382.33Molecular Weight (Monoisotopic): 382.1237AlogP: -1.15#Rotatable Bonds: 6Polar Surface Area: 166.92Molecular Species: NEUTRALHBA: 12HBD: 3#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.45CX Basic pKa: 3.71CX LogP: -1.19CX LogD: -1.19Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.41Np Likeness Score: 0.43
References 1. (2013) Method of reducing intraocular pressure in humans, 2. (2013) Purine derivatives as adenosine A1 receptor agonists and methods of use thereof,